Charity Treks

Charity Treks, Inc
Formation 2002
Headquarters Charlottesville, Virginia
Website www.charitytreks.org

Charity Treks, is a non-profit (501(c)(3)) organization dedicated to raising funds to research and develop a vaccine for HIV/AIDS.

History

Charity Treks was formed in 2002 by a group of cyclists who had participated in the 2001 Montreal to Maine AIDS Vaccine Bike Trek, one of the last AIDSRides produced by Pallotta Teamworks. The original event was organized by Palotta TeamWorks but was cancelled in 2002 due to funding issues. A group of riders continued to do the ride that year despite the lack of organizational structure.

The riders and volunteers were committed to the cause of raising the public awareness about AIDS, and felt compelled to not let this be a one-time event. As a result, a number or riders and volunteers gathered together to form a volunteer organization whose purpose is to forward the cause of AIDS awareness and raise funds for vital research in the development of a vaccine. 100% of funds raised are donated to the two charitable beneficiaries; Emory Vaccine Center and UCLA AIDS Institute

Past Events

2002 Montreal, QC to Portland, ME AIDS Vaccine Bike Trek
2003 Montreal, QC to Boston AIDS Vaccine Bike Trek
2004 Montreal, QC to Boston AIDS Vaccine Bike Trek
2005 Montreal, QC to Boston AIDS Vaccine Bike Trek
2006 Montreal, QC to Portland, ME AIDS Vaccine Bike Trek
2007 Montreal, QC to Portland, ME AIDS Vaccine Bike Trek
2008 Burlington, VT to Portland, ME AIDS Vaccine Bike Trek
2009 Burlington, VT to Portland, ME AIDS Vaccine Bike Trek
2010 Burlington, VT to Portland, ME AIDS Vaccine Bike Trek
2011 Montreal, QC to Portland, ME AIDS Vaccine Bike Trek
2012 Burlington, VT to Portland, ME AIDS Vaccine Bike Trek
2013 Burlington, VT to Portland, ME AIDS Vaccine Bike Trek
2014 Burlington, VT to Portland, ME AIDS Vaccine Bike Trek
2015 Charlottesville, VA to Washington, DC HIV/AIDS Vaccine Bike Trek

See also

References

    External links

    This article is issued from Wikipedia - version of the 1/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.